Nursing

AlayaCare Named Preferred Home Care Technology Partner by Closing the Gap Healthcare

TORONTO, ON / ACCESSWIRE / April 4, 2024 / Closing the Gap Healthcare (CTG) announced today that it has signed…

3 months ago

IHM Senior Living Community Becomes Licensed by the State of Michigan for Assisted Living Services

Community is now open for all levels of careMONROE, MI / ACCESSWIRE / April 4, 2024 / The IHM Senior…

3 months ago

Mars Veterinary Health pilots industry-leading anaesthetic gas capture technology to reduce carbon emissions

World's leading provider of veterinary care will be first to introduce innovative in-clinic solution to support sustainability goals BIRMINGHAM, England,…

3 months ago

Haven Health Care Announces Achievement of Expansion

BOCA RATON, FL / ACCESSWIRE / March 28, 2024 / Haven Health Care Services, a company that provides a wide…

4 months ago

Empathic Podiatry Selects eClinicalWorks Cloud EHR, Revenue Cycle Management and Robotic Process Automation to Improve Efficiency

Texas-based specialty practice chooses eClinicalWorks Cloud EHR to increase automation, streamline workflows, and enhance patient satisfactionWESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, the largest…

4 months ago

HCA Healthcare Releases 2024 Annual Impact Report

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced the release of its annual…

4 months ago

8-Year-Old Piano Prodigy Zeke Walters Strikes a Chord at Sinceri Senior Living Community

VANCOUVER, WA / ACCESSWIRE / March 22, 2024 / At just eight years old, Zeke Walters is proving that age…

4 months ago

Free Dementia Training in Alabama

Bring Dementia Education at No Cost to Your Skilled Nursing HomeTUSCALOOSA, AL / ACCESSWIRE / March 21, 2024 / Second…

4 months ago

Syllable Corporation Announces Purchase of Actium Health

Syllable expands artificial intelligence offerings to health systems through the purchase of Actium Health’s patient activation solution, thus furthering its…

4 months ago

Recce Pharmaceuticals Completes Dosing Cohort in Phase I/II Trial of RECCE® 327 for Urinary Tract Infections and Urosepsis

Four healthy subjects dosed with RECCE® 327 at 3,000mg over 20 minutesData received from this cohort will support preparations for…

4 months ago